Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT00898638
Collaborator
National Cancer Institute (NCI) (NIH)
8,000
4
573.6
2000
3.5

Study Details

Study Description

Brief Summary

RATIONALE: Collecting and storing samples of tissue, saliva, and blood from patients with cancer and from healthy participants to study in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing tissue samples from patients with head and neck cancer and from healthy participants.

Condition or Disease Intervention/Treatment Phase
  • Other: biologic sample preservation procedure
  • Other: medical chart review

Detailed Description

OBJECTIVES:
  • Maintain and update a clinical database pertaining to diagnosis and treatment outcome of patients with head and neck cancer.

  • Develop a repository of biospecimens from these patients.

OUTLINE: Tumor tissue samples and/or bronchial washings are collected from patients undergoing planned surgery and/or bronchoscopy, respectively. Buccal swabs and/or mouthwash samples and saliva samples are collected. Patients also undergo blood sample collection at baseline and then every 2-6 months thereafter.

Healthy participants contribute blood samples, buccal swabs, and mouthwash samples at baseline only.

Information about medical and family history and cancer risk factors is also collected.

PROJECTED ACCRUAL: No limit.

FOLLOW UP: Indefinite, until date of death or lost to follow up.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
8000 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Head and Neck Tumor Tissue Repository and Clinical Database
Actual Study Start Date :
Feb 13, 2003
Anticipated Primary Completion Date :
Dec 1, 2050
Anticipated Study Completion Date :
Dec 1, 2050

Arms and Interventions

Arm Intervention/Treatment
Healthy Volunteers

Non-tumor volunteers will be asked to participate at the time that they are attending a head and neck cancer screening clinic or at the time they are accompanying a patient to their appointment at the head and neck clinic. Intake sheets and biological specimens contributed by volunteers will be coded at the time of collection so that no identifiers are obtained. These specimens will not be linked to identifiers.

Other: biologic sample preservation procedure

Other: medical chart review

Head and Neck Tumor patients

Eligible patients will be identified at the Vanderbilt Head & Neck Clinic by clinical and research staff. An appropriately trained staff member will discuss the protocol with the patient (including, risks, benefits, alternatives, etc.).

Other: biologic sample preservation procedure

Other: medical chart review

Outcome Measures

Primary Outcome Measures

  1. Maintenance of a clinical database pertaining to diagnosis and treatment outcome of patients with head and neck cancer [ongoing]

    Collection of data for both groups from the Vanderbilt Otolaryngology Patient Intake questionnaire as well as the medical record, such as medical history, family history, and exposures to risk factors for cancer (tobacco and alcohol use), and results of tests related to diagnosis of tumor and treatment response (for tumor patients only).

  2. Development of a repository of biospecimens [ongoing]

    Collection of blood, tissue, saliva, bronchial washings and other specimens as indicated from both tumor and healthy patients.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
DISEASE CHARACTERISTICS:
  • Meets 1 of the following criteria:

  • Diagnosis of head and neck cancer

  • Being treated at Vanderbilt University Medical Center for the cancer

  • Healthy participant

PATIENT CHARACTERISTICS:
  • Not specified
PRIOR CONCURRENT THERAPY:
  • Not specified

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville Tennessee United States 37064
2 Vanderbilt-Ingram Cancer Center at Franklin Nashville Tennessee United States 37064
3 Veterans Affairs Medical Center - Nashville Nashville Tennessee United States 37212
4 Vanderbilt-Ingram Cancer Center Nashville Tennessee United States 37232-6838

Sponsors and Collaborators

  • Vanderbilt University Medical Center
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Eben Rosenthal, MD, Vanderbilt University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eben Rosenthal, Dept Chairperson Professor, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT00898638
Other Study ID Numbers:
  • CDR0000546682
  • P30CA068485
  • VU-VICC-HN-0356
  • VU-VICC-IRB-030062
First Posted:
May 12, 2009
Last Update Posted:
Nov 15, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eben Rosenthal, Dept Chairperson Professor, Vanderbilt University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2021